A Study Study to Investigate the Effect on QT/QTc Interval of Moxifloxacin After a Single Dose in Healthy Male Subjects
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate effect of moxifloxacin on QT/QTc interval in healthy
male subjects. Moxifloxacin is a positive control drug used in QT study. In this study,
moxifloxacin 400mg and 800mg will be used, to get information on effect of moxifloxacin on
QT/QTc interval.
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Korea National Enterprise for Clinical Trials Seoul National University Bundang Hospital The Catholic University of Korea
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination